The rat hepatic CYP2EI gene becomes transcriptionally activated within 1 day after birth. This activation can be mimicked by using the 5' end of the gene in a cell-free nuclear extract prepared from hepatocytes taken from rats at different developmental stages. Deletion analysis revealed that a positive element located between -127 and -89 was responsible for 90% of the in vitro transcription activity of adult liver extracts. Protein binding studies revealed that this region was operationally equivalent to the binding site for the factor HNF-1. Two other protein-binding regions were uncovered, one of which corresponded to the site for a CCAATbinding factor NFY. The other site was a palindrome sequence unique to the CYP2EI gene. These latter two factors did not significantly contribute to transcriptional activity in vitro and were not conserved between the rat and human CYP2EI genes. Extracts prepared from fetal and newborn livers were transcriptionally inactive, whereas extracts from livers of 3-day-old rats were fully active toward the CYP2EI gene. DNase I footprinting patterns indistinguishable between fetal and adult extracts were obtained for all three factors. However, gel mobility shift assays revealed a second, higher-mobility band produced by fetal and newborn liver extracts bound to the HNF-1 oligomer. UV-cross-linking studies showed that adult and fetal extracts had only a single 98-kilodalton protein that bound to this oligomer. In contrast, adult lung samples, also transcriptionally inactive toward the CYP2EI gene, contained two proteins of slightly greater than 110 kilodaltons. These results suggest that the CYP2EI gene is positively regulated in adult rats by HNF-1 or a protein similar in DNA-binding properties to HNF-1. The role of this factor or other protein-protein interactions in the lack of CYP2EI transcription in fetal and newborn animals remains unclear.Control of gene transcription has been extensively studied in rat hepatocytes. A number of transcriptional activator proteins have been found to control liver-specific gene transcription (reviewed in reference 17). Several of these, including HNF-1 (2, 8), C/EBP (21), and DBP (26), have been cloned. Other factors such as HNF-3 and HNF-4 that are rich in hepatocytes and hepatoma cells have also been identified (6). Indeed, control of hepatic gene expression may involve combinational participation of two or more factors acting on multiple individual subdomains upstream of the transcription start site (17).The cytochrome P-450s represent a superfamily of gene products (13, 27). Many P-450s, especially those involved in drug oxidation, are expressed primarily in liver, although some forms are produced to a lesser extent in tissues such as lung, kidney, and intestine. A number of P-450 genes are expressed at low or undetectable levels unless the animal is administered inducing agents such as the dioxins, phenobarbital, synthetic steroids, and hypolipidemic agents. Other P-450 genes are actively transcribed in the absence of inducers. Many of thes...